Investing.com - CorMedix reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
CorMedix announced earnings per share of $-0.170 on revenue of $6.81M. Analysts polled by Investing.com anticipated EPS of $-0.240 on revenue of $0.
CorMedix shares are down 24% from the beginning of the year and are trading at $3.140 , down-from-52-week-high.
CorMedix shares gained 10.95% in pre-market trade the report.
CorMedix follows other major Healthcare sector earnings this month
CorMedix's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar